Like intravenous immunoglobulin therapy,<unk>  contains a mixture of neutralizing antibodies that confer passive immunity to an individual, enhancing the normal immune response, and is designed to be administered after exposure to the Ebola virus. Such antibodies have been used in the treatment and prevention of various infectious diseases and are intended to attack the virus by interfering with its surface and neutralizing it to prevent further damage.The Nicotiana benthamiana tobacco plant
ZMapp
ICES
E-med
RTS,S
MD&DI
QL 
IPrEx
NLM